Syschem (India) Limited (BOM:531173)

Market Cap	2.42B +35.7%
Revenue (ttm)	6.55B +69.5%
Net Income	109.29M +2,275.4%
EPS	1.93 +1,670.7%
Shares Out	49.01M
PE Ratio	25.59
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	149,303
Open	53.25
Previous Close	51.05
Day's Range	49.00 - 53.25
52-Week Range	40.50 - 62.00
Beta	-0.39
Analysts	n/a
Price Target	n/a
Earnings Date	May 25, 2026

About Syschem (India)

Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and ...

• Industry: Industrial Organic Chemicals
• Founded: 1993
• Employees: 115
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531173

Financial Performance

In fiscal year 2026, Syschem (India)'s revenue was 6.55 billion, an increase of 69.50% compared to the previous year's 3.86 billion. Earnings were 109.29 million, an increase of 2275.35%.